Yakult Honsha to Bring to Market New Intestinal Remedy in June.Tokyo, Japan, May 19, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Yakult will launch Yakult BL Seichoyaku S-Tablet, its proprietary product for regulating intestinal function, on June 8. The new product contains a lactic acid lactic acid, CH3CHOHCO2H, a colorless liquid organic acid. It is miscible with water or ethanol. Lactic acid is a fermentation product of lactose (milk sugar); it is present in sour milk, koumiss, leban, yogurt, and cottage cheese. bacillus bacillus (bəsĭl`əs), any rod-shaped bacterium or, more particularly, a rod-shaped bacterium of the genus Bacillus. Some bacterium in the genus cause disease, for example B. L. casei strain Shirota and a bifidobacterium, B. breve BREVE, practice. A writ in which the cause of action is briefly stated, hence its name. Fleta, lib. 2, c. 13, Sec. 25; Co. Lit. 73 b. 2. Writs are distributed into several classes. strain Yakult, and helps alleviate abdominal distension, loose stools, and constipation. The new strawberry-flavored chewable tablet can be taken by 5-year-old infants to adults. It comes in 27-tablet and 108-tablet bottles, which retail for 635 yen ($5.60) and 1,650 yen ($14.70), respectively. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion